Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitope

Immunology and Cell Biology

Volumn 90, Issue 10, 2012, Pages 978-982

  Johnstone, Carolina ^a   Ramos, Manuel ^a   García Barreno, Blanca ^a,b   López, Daniel ^a   Melero, José A ^a,b   Del Val, Margarita ^a,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Antigen processing; Autophagy; CTL; MHC class I; TAP; Virus

Indexed keywords

BREFELDIN A; EPITOPE; HYBRID PROTEIN; LACTACYSTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEASOME INHIBITOR; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; AUTOPHAGY; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LOWER RESPIRATORY TRACT INFECTION; LUNG; LYSOSOME; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; T LYMPHOCYTE ACTIVATION;

AGED; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, LY; ANTIGENS, VIRAL; AUTOPHAGY; CELL LINE; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; LYSOSOMES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL VACCINES;

MURINAE; MUS; RESPIRATORY SYNCYTIAL VIRUS; VACCINIA VIRUS;

EID: 84870487694     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2012.43     Document Type: Article

References (28)

1. Johnstone C, Del Val M. Traffic of proteins and peptides across membranes for immunosurveillance by CD8+ T lymphocytes: a topological challenge. Traffic 2007; 8: 1486-1494.
2. Del Val M, Iborra S, Ramos M, Lázaro S. Generation of MHC class I ligands in the secretory and vesicular pathways. Cell Mol Life Sci 2011; 68: 1543-1552.
3. Collins PL, Chanock RM, Murphy BR. Respiratory syncytial virus. In: Knipe DM and Howley PM (eds) Fields Virology. Lippincott Williams & Wilkins, Philadelphia, PA, 2001: 1443-1485.
4. Olmsted RA, Elango N, Prince GA, Murphy BR, Johnson PR, Moss B et al. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc Natl Acad Sci USA 1986; 83: 7462-7466.
5. Pemberton RM, Cannon MJ, Openshaw PJM, Ball LA, Wertz GW, Askonas BA. Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. J Gen Virol 1987; 68: 2177-2182.
6. Cannon MJ, Openshaw PJ, Askonas BA. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 1988; 168: 1163-1168.
7. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991; 88: 1026-1033.
8. Johnstone C, de León P, Medina F, Melero JA, García-Barreno B, Del Val M. Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus. J Gen Virol 2004; 85: 3229-3238.
9. Johnstone C, Guil S, García-Barreno B, López D, Melero JA, Del Val M. Relevance of viral context and diversity of antigen processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes. J Gen Virol 2008; 89: 2194-2203.
10. Grommé M, Uytdehaag FGCM, Janssen H, Calafat J, van Binnendijk RS, Kenter MJH et al. Recycling MHC class I molecules and endosomal peptide loading. Proc Natl Acad Sci USA 1999; 96: 10326-10331.
11. Schirmbeck R, Reimann J. Alternative processing of endogenous or exogenous antigens extends the immunogenic, H-2 class I-restricted peptide repertoire. Mol Immunol 2002; 39: 249-259.
12. Neumeister C, Nanan R, Cornu TI, Lüder CGK, ter Meulen V, Naim H et al. Measles virus and canine distemper virus target proteins into a TAP-independent MHC class I-restricted antigen-processing pathway. J Gen Virol 2001; 82: 441-447.
13. Blanchet FP, Moris A, Nikolic DS, Lehmann M, Cardinaud S, Stalder R et al. Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 2010; 32: 654-669.
14. Lee HK, Mattei LM, Steinberg BE, Alberts P, Lee YH, Chervonsky A et al. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 2010; 32: 227-239.
15. Umezawa H. Structures and activities of protease inhibitors of microbial origin. Methods Enzymol 1976; 45: 678-695.
16. Seglen PO, Gordon PB. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci USA 1982; 79: 1889-1892.
17. Hendil KB, Lauridsen AM, Seglen PO. Both endocytic and endogenous protein degradation in fibroblasts is stimulated by serum/amino acid deprivation and inhibited by 3-methyladenine. Biochem J 1990; 272: 577-581.
18. Shen L, Sigal LJ, Boes M, Rock KL. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 2004; 21: 155-165.
19. Laliberte JP, Weisberg AS, Moss B. The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components. PLoS Pathog 2011; 7: e1002446.
20. Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, Magalhaes JG et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010; 11: 55-62.
21. English L, Chemali M, Duron J, Rondeau C, Laplante A, Gingras D et al. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 2009; 10: 480-487.
22. Tey SK, Khanna R. Autophagy mediates transporter associated with antigen processing-independent presentation of viral epitopes through MHC class I pathway. Blood 2012; 120: 994-1004.
23. Schmid D, Münz C. Innate and adaptive immunity through autophagy. Immunity 2007; 27: 11-21.
24. López JA, Bustos R,Örvell C, Berois M, Arbiza J, García-Barreno B et al. Antigenic structure of human respiratory syncytial virus fusion glycoprotein. J Virol 1998; 72: 6922-6928.
25. Bembridge GP, López JA, Cook R, Melero JA, Taylor G. Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon. J Virol 1998; 72: 4080-4087.
26. Bembridge GP, López JA, Bustos R, Melero JA, Cook R, Mason H et al. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge. J Virol 1999; 73: 10086-10094.
27. Sathe P, Pooley J, Vremec D, Mintern J, Jin JO, Wu L et al. The acquisition of antigen cross-presentation function by newly formed dendritic cells. J Immunol 2011; 186: 5184-5192.
28. Eisenlohr LC, Yewdell JW, Bennink Jr. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J Exp Med 1992; 175: 481-487.